Performance analysis of LB Pharmaceuticals (LBRX)
Annual Return
Since Sep 11, 2025, LBRX has had an average annual return of +85.23%, outperforming the benchmark SPY, which returned +23.48% annual.
| 2026 | 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +21.38% | +28.67% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.64% | +11.94% | +2.70% | +28.59% | -11.79% | -3.40% | +21.38% | ||||||
| 2025 | -8.73% | +2.16% | +10.29% | +25.13% | +28.67% |
Drawdown analysis of LB Pharmaceuticals (LBRX)
The maximum drawdown for the LBRX was -17.83%, occurring on Jun 2, 2026. This drawdown has not yet recovered.
The current LBRX drawdown is -17.83%.
Since Sep 11, 2025 LBRX has experienced the following drawdowns:
- 10% or more: 6 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -17.83% | May 5, 2026 | 19 | Jun 2, 2026 | Ongoing | Ongoing | Ongoing |
| -15.57% | Dec 22, 2025 | 13 | Jan 12, 2026 | 7 | Jan 22, 2026 | 20 |
| -15.55% | Sep 11, 2025 | 42 | Nov 10, 2025 | 13 | Nov 28, 2025 | 55 |
| -15.33% | Dec 8, 2025 | 7 | Dec 17, 2025 | 3 | Dec 22, 2025 | 10 |
| -12.13% | Mar 16, 2026 | 10 | Mar 30, 2026 | 4 | Apr 6, 2026 | 14 |
| -11.46% | Jan 23, 2026 | 4 | Jan 29, 2026 | 7 | Feb 9, 2026 | 11 |
| -9.65% | Apr 6, 2026 | 4 | Apr 10, 2026 | 3 | Apr 15, 2026 | 7 |
| -6.32% | Feb 25, 2026 | 6 | Mar 5, 2026 | 6 | Mar 13, 2026 | 12 |
| -4.15% | Feb 12, 2026 | 1 | Feb 13, 2026 | 6 | Feb 24, 2026 | 7 |
| -3.83% | Apr 27, 2026 | 2 | Apr 29, 2026 | 3 | May 4, 2026 | 5 |
| -3.30% | Apr 21, 2026 | 3 | Apr 24, 2026 | 1 | Apr 27, 2026 | 4 |
| -2.88% | Apr 15, 2026 | 1 | Apr 16, 2026 | 1 | Apr 17, 2026 | 2 |
| -2.02% | Nov 28, 2025 | 1 | Dec 1, 2025 | 1 | Dec 2, 2025 | 2 |
| -0.54% | Feb 10, 2026 | 1 | Feb 11, 2026 | 1 | Feb 12, 2026 | 2 |